Neil Kopek

Summary

Publications

  1. ncbi Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    Radiother Oncol 93:402-7. 2009
  2. ncbi Stereotactic body radiotherapy for unresectable cholangiocarcinoma
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Building 5, 8000 Aarhus C, Denmark
    Radiother Oncol 94:47-52. 2010

Detail Information

Publications2

  1. ncbi Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    Radiother Oncol 93:402-7. 2009
    ..To determine the prognostic role of co-morbidity in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT)...
  2. ncbi Stereotactic body radiotherapy for unresectable cholangiocarcinoma
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Building 5, 8000 Aarhus C, Denmark
    Radiother Oncol 94:47-52. 2010
    ..To report outcomes of a single institution study of stereotactic body radiotherapy (SBRT) for unresectable cholangiocarcinoma. The dose-volume dependency of the observed gastrointestinal toxicity is explored...